Hepatic artery aneurysm rupture into the biliary tract during long-term left ventricular assist device support successfully treated by transcatheter arterial embolization: a case report.
{"title":"Hepatic artery aneurysm rupture into the biliary tract during long-term left ventricular assist device support successfully treated by transcatheter arterial embolization: a case report.","authors":"Fumika Haga, Takamasa Sato, Koji Owada, Satoshi Okochi, Ryo Ogawara, Keiichiro Endo, Fumiya Anzai, Yu Sato, Yoshiaki Katada, Yasuchika Takeishi","doi":"10.1007/s10047-026-01566-7","DOIUrl":null,"url":null,"abstract":"<p><p>Bleeding complications remain a major concern in patients supported by long-term left ventricular assist devices (LVADs). Although gastrointestinal bleeding is common, hemobilia due to rupture of a hepatic artery aneurysm is extremely rare. A 47-year-old man with end-stage heart failure underwent implantation of a continuous-flow LVAD as a bridge to transplantation and was maintained on long-term anticoagulation therapy. He developed anemia with abdominal pain and melena. Imaging at the first hospitalization revealed a hepatic artery aneurysm with suspected hemobilia. After temporary stabilization, he was readmitted with recurrent melena and abdominal pain. Subsequent imaging demonstrated rapid aneurysmal enlargement with rupture into the biliary tract. Emergency angiography followed by transcatheter arterial embolization using detachable coils and n-butyl cyanoacrylate achieved complete hemostasis while preserving hepatic arterial flow. Anticoagulation was resumed without thrombotic complications, and the patient subsequently underwent successful transplantation without recurrence. Hepatic artery aneurysm rupture into the biliary tract is a rare but life-threatening complication in patients receiving long-term LVAD support. Prompt multidisciplinary management and endovascular intervention are essential for favorable outcomes.</p>","PeriodicalId":15177,"journal":{"name":"Journal of Artificial Organs","volume":"29 3","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2026-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Artificial Organs","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s10047-026-01566-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Bleeding complications remain a major concern in patients supported by long-term left ventricular assist devices (LVADs). Although gastrointestinal bleeding is common, hemobilia due to rupture of a hepatic artery aneurysm is extremely rare. A 47-year-old man with end-stage heart failure underwent implantation of a continuous-flow LVAD as a bridge to transplantation and was maintained on long-term anticoagulation therapy. He developed anemia with abdominal pain and melena. Imaging at the first hospitalization revealed a hepatic artery aneurysm with suspected hemobilia. After temporary stabilization, he was readmitted with recurrent melena and abdominal pain. Subsequent imaging demonstrated rapid aneurysmal enlargement with rupture into the biliary tract. Emergency angiography followed by transcatheter arterial embolization using detachable coils and n-butyl cyanoacrylate achieved complete hemostasis while preserving hepatic arterial flow. Anticoagulation was resumed without thrombotic complications, and the patient subsequently underwent successful transplantation without recurrence. Hepatic artery aneurysm rupture into the biliary tract is a rare but life-threatening complication in patients receiving long-term LVAD support. Prompt multidisciplinary management and endovascular intervention are essential for favorable outcomes.
期刊介绍:
The aim of the Journal of Artificial Organs is to introduce to colleagues worldwide a broad spectrum of important new achievements in the field of artificial organs, ranging from fundamental research to clinical applications. The scope of the Journal of Artificial Organs encompasses but is not restricted to blood purification, cardiovascular intervention, biomaterials, and artificial metabolic organs. Additionally, the journal will cover technical and industrial innovations. Membership in the Japanese Society for Artificial Organs is not a prerequisite for submission.